Biochemistry professor Joanne Lemieux leads a U of A team that identified promising compounds known as protease inhibitors that interfere with the SARS-CoV-2 virus’s ability to replicate — potentially pointing the way to new antiviral treatments that would be more effective with fewer toxic side-effects. (Photo: John Ulan)